Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction

Figure 3

The multivariate Cox regression analysis for hazard of death (survival). Multivariate analysis failed to show a significant improvement in mortality with GP IIb/IIIa inhibitor use. In addition to increased patient age, a history of myocardial infarction (MI), cerebrovascular accident (CVA), diabetes mellitus (DM), and renal disease remained significant predictors of increased mortality. Drug-eluting stents continued to be associated with improved survival.